Employers and drugmakers are eager to say good riddance to an excise tax on brand-name prescription medicines (the BPD) that could get stripped under the latest GOP plan to repeal Obamacare.
Employers and drugmakers are eager to say good riddance to an excise tax on brand-name prescription medicines (the BPD) that could get stripped under the latest GOP plan to repeal Obamacare.